These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 24486453)
21. Cellular associations of pituitary gonadotrophs in a rodent (Lagostomus maximus maximus) with photoperiod-dependent reproduction. Filippa V; Acosta M; Mohamed F Tissue Cell; 2012 Dec; 44(6):351-7. PubMed ID: 22749373 [TBL] [Abstract][Full Text] [Related]
22. Lack of long-lasting effects of mitotane adjuvant therapy in a mouse xenograft model of adrenocortical carcinoma. Doghman M; Lalli E Mol Cell Endocrinol; 2013 Dec; 381(1-2):66-9. PubMed ID: 23906534 [TBL] [Abstract][Full Text] [Related]
23. Effects of differential pulse frequencies of chicken gonadotrophin-releasing hormone-I (cGnRH-I) on laying hen gonadotrope responses in vitro. Soñez MC; Soñez CA; Mugnaini MT; Haedo M; Romera SA; Lombardo DM; Delhon GA Biotech Histochem; 2010 Dec; 85(6):355-63. PubMed ID: 19909216 [TBL] [Abstract][Full Text] [Related]
24. GnRH increases glucose transporter-1 expression and stimulates glucose uptake in the gonadotroph. Harris VM; Bendre SV; Gonzalez De Los Santos F; Fite A; El-Yaman El-Dandachli A; Kurenbekova L; Abou-Samra AB; Buggs-Saxton C J Endocrinol; 2012 Feb; 212(2):139-47. PubMed ID: 22107955 [TBL] [Abstract][Full Text] [Related]
25. Neuropeptide glutamic-isoleucine (NEI) specifically stimulates the secretory activity of gonadotrophs in primary cultures of female rat pituitary cells. De Paul AL; Attademo AM; Carón RW; Soaje M; Torres AI; Jahn GA; Celis ME Peptides; 2009 Nov; 30(11):2081-7. PubMed ID: 19729046 [TBL] [Abstract][Full Text] [Related]
26. The ovary-mediated FSH attenuation of the LH surge in the rat involves a decreased gonadotroph progesterone receptor (PR) action but not PR expression. Gordon A; Garrido-Gracia JC; Aguilar R; Bellido C; Velasco JA; Millan Y; Tena-Sempere M; Martín de Las Mulas J; Sánchez-Criado JE J Endocrinol; 2008 Mar; 196(3):583-92. PubMed ID: 18310454 [TBL] [Abstract][Full Text] [Related]
27. A study of the endocrine manifestations of hepatic cirrhosis. Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039 [TBL] [Abstract][Full Text] [Related]
31. Effects of mitotane on gene expression in the adrenocortical cell line NCI-H295R: a microarray study. Zsippai A; Szabó DR; Tömböl Z; Szabó PM; Eder K; Pállinger E; Gaillard RC; Patócs A; Tóth S; Falus A; Rácz K; Igaz P Pharmacogenomics; 2012 Sep; 13(12):1351-61. PubMed ID: 22966885 [TBL] [Abstract][Full Text] [Related]
32. Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells. Hescot S; Slama A; Lombès A; Paci A; Remy H; Leboulleux S; Chadarevian R; Trabado S; Amazit L; Young J; Baudin E; Lombès M Endocr Relat Cancer; 2013 Jun; 20(3):371-81. PubMed ID: 23696597 [TBL] [Abstract][Full Text] [Related]
33. Two types of secretory granules in gonadotrophs: discrimination by the simultaneous EM immunocytochemical localization of serotonin and beta-follicle stimulating hormone. Payette RF; Gershon MD; Nunez EA Anat Rec; 1987 Dec; 219(4):394-401. PubMed ID: 3129965 [TBL] [Abstract][Full Text] [Related]
34. Modulation of proteomic profile in H295R adrenocortical cell line induced by mitotane. Stigliano A; Cerquetti L; Borro M; Gentile G; Bucci B; Misiti S; Piergrossi P; Brunetti E; Simmaco M; Toscano V Endocr Relat Cancer; 2008 Mar; 15(1):1-10. PubMed ID: 18310271 [TBL] [Abstract][Full Text] [Related]
35. Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines. Cerquetti L; Bucci B; Marchese R; Misiti S; De Paula U; Miceli R; Muleti A; Amendola D; Piergrossi P; Brunetti E; Toscano V; Stigliano A Endocr Relat Cancer; 2008 Jun; 15(2):623-34. PubMed ID: 18509009 [TBL] [Abstract][Full Text] [Related]
37. Foetal exposure to mitotane/Op'DDD: Post-natal study of four children. Magkou D; Do Cao C; Bouvattier C; Douillard C; de Marcellus C; Cazabat L; Gérard M; Raffin-Sanson ML; Young J Clin Endocrinol (Oxf); 2018 Dec; 89(6):805-812. PubMed ID: 30222204 [TBL] [Abstract][Full Text] [Related]
38. Withdrawal of mitotane. Macholc EJ Vet Rec; 1989 Feb; 124(7):177. PubMed ID: 2922918 [No Abstract] [Full Text] [Related]
39. Pituitary function: Mitotane--safe and effective for Cushing disease? Ozerlat I Nat Rev Endocrinol; 2012 Oct; 8(10):565. PubMed ID: 22869359 [No Abstract] [Full Text] [Related]
40. The effect of adjuvant mitotane therapy of the adrenocortical carcinoma on the endometrium and its clinical consequences in menstruating women. Literature review and authors' own experiences. Szkodziak P; Szkodziak F; Korolczuk A; Obel E; Woźniak S; Paszkowski T Am J Cancer Res; 2024; 14(4):1802-1814. PubMed ID: 38726272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]